rivaroxaban

Barsovi is used by adults for several conditions: to reduce the risk of heart attack or death in the event of acute coronary syndrome; to prevent the formation of blood clots after hip or knee replacement surgery; to treat and prevent the recurrence of blood clots in the leg veins (deep vein thrombosis) and in the lungs (pulmonary embolism); and to prevent stroke in people with non-valvular atrial fibrillation.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: SUMAR PHARMA EHF.

This medicine is used by adults to prevent the formation of blood clots (such as a stroke) in the case of non-valvular atrial fibrillation, or to treat and prevent the recurrence of clots in the veins of the legs (deep vein thrombosis) and in the lungs (pulmonary embolism). It is also used to prevent clots after hip or knee replacement surgery. In children and adolescents weighing more than 30 kg, it is used to treat clots following initial treatment with injectable drugs.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: ELLEVA PHARMA SRL

The medicine is used by adults to prevent the formation of blood clots (such as stroke, deep vein thrombosis, or pulmonary embolism) in various conditions, including after hip or knee replacement surgery or in the case of atrial fibrillation. It is also used in children and adolescents weighing more than 30 kg to treat blood clots in the lungs or the veins of the legs.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: ERREKAPPA EUROTERAPICI S.P.A.

This medicine is used to reduce the risk of blood clot formation (such as heart attacks, strokes, or pulmonary embolism) in several conditions, including acute coronary syndrome, atrial fibrillation, deep vein thrombosis, and the prevention of clots after hip or knee replacement surgery.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: ACCORD HEALTHCARE, S.L.U.

This medicine is used by adults to prevent the formation of blood clots (such as a stroke or clots in the veins after hip or knee replacement surgery) and to treat existing clots in the leg veins or lungs. It is also used in children and adolescents weighing over 30 kg to treat and prevent the recurrence of clots in the lungs or veins following initial treatment with injectable medicines.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: LABORATORI ALTER S.R.L.

This medicine is used by adults to prevent the formation of blood clots (such as a stroke or clots in the veins after hip or knee replacement surgery) and to treat existing clots in the leg veins or lungs. It is also indicated for children and adolescents (weighing more than 30 kg) to treat clots following initial treatment with injectable drugs.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: AUROBINDO PHARMA (ITALIA) S.R.L.

This medicine is an antithrombotic agent used to reduce the risk of blood clot formation. It is prescribed for several conditions, including acute coronary syndrome, the risk of clots due to arterial disease, the prevention of clots after hip or knee replacement surgery, the treatment of deep vein thrombosis and pulmonary embolism, and to prevent stroke in adults with non-valvular atrial fibrillation.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: CIPLA EUROPE NV

This medicine is used for several purposes: to reduce the risk of heart attacks or death in patients with acute coronary syndrome; to prevent the formation of blood clots in the veins after hip or knee replacement surgery; to treat blood clots in the veins of the legs (deep vein thrombosis) and in the lungs (pulmonary embolism); and to prevent stroke in adults with non-valvular atrial fibrillation. It is also indicated for children and adolescents (over 30 kg) for the treatment of venous clots.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: DOC GENERICI SRL

This medicine is used by adults to prevent the formation of blood clots (such as a stroke) in cases of atrial fibrillation, or to treat and prevent clots in the leg veins (deep vein thrombosis) and the lungs (pulmonary embolism). It is also prescribed to reduce the risk of heart attacks or death in patients with acute coronary syndrome or peripheral artery disease.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: HCS BV

This medicine is used by adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery, to treat deep vein thrombosis and pulmonary embolism, and to prevent the recurrence of such clots. In adults, it is also used to prevent stroke in those suffering from non-valvular atrial fibrillation. In children and adolescents weighing 30 kg or more, it is used to treat clots in the lungs or veins following initial treatment with injectable drugs.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: IBSA FARMACEUTICI ITALIA S.R.L.

This medicine is used for several conditions: in adults, it is used to prevent the formation of blood clots in the brain (stroke) and in other blood vessels in the case of atrial fibrillation; to treat and prevent the recurrence of blood clots in the leg veins (deep vein thrombosis) and in the lungs (pulmonary embolism); and to reduce the risk of heart attacks or death in patients with acute coronary syndrome or a high risk of clots due to arterial disease. In children and adolescents (over 30 kg), it is used to treat blood clots in the veins or lungs following initial treatment with injectable drugs.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: MEDICAL VALLEY INVEST AB

It is used by adults to prevent the formation of blood clots (such as a stroke or clots in the leg veins and lungs) in cases of atrial fibrillation or after hip or knee replacement surgery. It is also used in children and adolescents weighing over 30 kg to treat and prevent the recurrence of clots after initial treatment with injectable medicines.

Form: capsules, hard gelatin

ATC: B01AF01

Manufacturer: MYLAN S.P.A.

This medicine is used to reduce the risk of blood clot (thrombus) formation in several conditions: to prevent stroke and vascular problems in adults with atrial fibrillation, to treat and prevent deep vein thrombosis and pulmonary embolism, and to prevent clot formation after hip or knee replacement surgery. It is also indicated for adults with acute coronary syndrome or a high risk of clots due to coronary or peripheral artery disease.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: OLPHA AS

This medicinal product is used to prevent the formation of blood clots (such as stroke, deep vein thrombosis, or pulmonary embolism) in several conditions, including acute coronary syndrome, non-valvular atrial fibrillation, or in patients undergoing hip or knee replacement surgery.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: ZAKLADY FARMACEUTYCZNE POLPHARMA SA

It is used by adults to prevent the formation of blood clots (such as stroke or pulmonary embolism) in cases of atrial fibrillation, acute coronary syndrome, or arterial disease. It is also used to treat clots in the leg veins or lungs and to prevent them from reappearing after hip or knee replacement surgery. In children and adolescents (over 30 kg), it is used to treat clots following initial treatment with injectable medications.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: SUN PHARMACEUTICAL INDUSTRIES (EUROPE) B.V.

This medicine is used in adults to prevent the formation of blood clots (such as stroke or deep vein thrombosis) in cases of atrial fibrillation or after hip or knee replacement surgery. It is also used to treat existing clots in the leg veins or lungs and to prevent them from reappearing. In children and adolescents weighing more than 30 kg, it is used to treat and prevent clots following initial treatment with injectable medicines.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: TECNIGEN S.R.L.

This medicine is used to reduce the risk of blood clot formation (such as stroke, heart attacks, or deep vein thrombosis) in several conditions, including acute coronary syndrome, atrial fibrillation, deep vein thrombosis, and pulmonary embolism, or to prevent their recurrence after hip or knee replacement surgery.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: TEVA ITALIA S.R.L.

This medicine is used to reduce the risk of blood clot formation (such as stroke or heart attacks) in people with acute coronary syndrome, coronary artery disease or peripheral artery disease, or atrial fibrillation. It is also used to treat and prevent deep vein thrombosis and pulmonary embolism, and to prevent clots after hip or knee replacement surgery.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: TILLOMED ITALIA SRL

This medicine is used for several conditions: in adults, it is used to reduce the risk of heart attacks or death in the event of acute coronary syndrome, to prevent the formation of blood clots in the case of arterial disease, to treat or prevent deep vein thrombosis and pulmonary embolism, and to prevent stroke in people with atrial fibrillation. It is also indicated to prevent blood clots after hip or knee replacement surgery. In children and adolescents (over 30 kg), it is used to treat blood clots in the veins or lungs after initial treatment with injectable medicines.

Form: tablets

ATC: B01AF01

Manufacturer: VIATRIS LIMITED

This medicine is used by adults to prevent the formation of blood clots after hip or knee replacement surgery, to treat blood clots in the leg veins (deep vein thrombosis) or in the lungs (pulmonary embolism), and to prevent them from reappearing. In adults, it is also used to prevent stroke in those suffering from non-valvular atrial fibrillation. It is also used in children and adolescents (based on specific weight) to treat blood clots in the lungs or veins.

Form: capsules, hard gelatin

ATC: B01AF01

Manufacturer: ZENTIVA ITALIA S.R.L.

This medicine is used to reduce the risk of blood clot formation (such as stroke or heart attacks) in patients with acute coronary syndrome or arterial disease. It is also used to prevent clots after hip or knee replacement surgery, to treat deep vein thrombosis and pulmonary embolism, and to prevent non-valvular atrial fibrillation.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: ZENTIVA ITALIA S.R.L.

Rixacam is used by adults to prevent the formation of blood clots (such as stroke or deep vein thrombosis) in several conditions, including atrial fibrillation, acute coronary syndrome, or after hip or knee replacement surgery. It is also used to treat existing clots in the veins of the legs or in the lungs.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: ADAMED S.R.L.

Xarelto is used for several purposes depending on the situation: in adults, it may be used to reduce the risk of heart attacks or death from heart disease, to prevent the formation of clots in the case of arterial disease, to treat deep vein thrombosis and pulmonary embolism, or to prevent stroke in those suffering from atrial fibrillation. In children and adolescents, it is used to treat blood clots in the blood vessels of the legs or lungs.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: BAYER AG